CAS No. |
1177-14-6 |
中文名称 |
4,4'-(四氢-1H,3H-呋喃并[3,4-c]呋喃-1,4-二基)双(2,6-二甲氧基苯酚) |
英文名称 |
4,4'-(Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis(2,6-dimethoxyphenol) |
别名 |
(+)-Syringaresinol;DL-Syringaresil;4,4'-(1S,3aR,4S,6aR)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbi s(2,6-dimethoxyphenol);Phenol, 4,4'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis[2,6-dimethoxy-, (1R,3aS,4R,6aS)-rel-;(+)-syringaresionol;(?)-Syringaresinol;DL-Syringaresinol, 10 mM in DMSO;(+/-)-Syringaresinol |
标准英文名 |
4,4'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis(2,6-dimethoxyphenol) |
分子式 |
C22H26O8 |
分子量 |
418.44
|
精确分子量 |
418.16
|
SMILES |
COC1=C(O)C(OC)=CC(C(OCC23)C2COC3C4=CC(OC)=C(O)C(OC)=C4)=C1 |
标准SMILES |
COC1C=C(C=C(OC)C=1O)C1OCC2C(OCC21)C1=CC(OC)=C(O)C(=C1)OC |
用途 |
DL-Syringaresinol exhibits anti-photoaging properties by inhibiting UVA-induced MMP-1 upregulation via suppression of the MAPK/AP-1 signaling pathway in human HaCaT keratinocytes and dermal fibroblasts (HDF); it also shows weak anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv. |
InChIKey |
KOWMJRJXZMEZLD-UHFFFAOYSA-N |